GRANITO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 408
EU - Europa 318
AS - Asia 116
AF - Africa 31
OC - Oceania 7
SA - Sud America 7
Totale 887
Nazione #
US - Stati Uniti d'America 402
IT - Italia 133
IE - Irlanda 45
CN - Cina 33
ES - Italia 29
DE - Germania 28
SE - Svezia 27
IN - India 18
GB - Regno Unito 14
SD - Sudan 14
SG - Singapore 8
TR - Turchia 8
ZA - Sudafrica 8
AU - Australia 7
NL - Olanda 7
SA - Arabia Saudita 7
FI - Finlandia 6
HK - Hong Kong 6
IQ - Iraq 6
JP - Giappone 6
BE - Belgio 5
CM - Camerun 5
FR - Francia 5
IR - Iran 5
AR - Argentina 4
CA - Canada 4
GR - Grecia 4
PH - Filippine 3
RU - Federazione Russa 3
TH - Thailandia 3
VN - Vietnam 3
BD - Bangladesh 2
BO - Bolivia 2
EG - Egitto 2
IL - Israele 2
LU - Lussemburgo 2
MX - Messico 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
KR - Corea 1
LB - Libano 1
MA - Marocco 1
MT - Malta 1
PS - Palestinian Territory 1
TW - Taiwan 1
UA - Ucraina 1
Totale 887
Città #
Bologna 58
Dublin 45
Ashburn 41
Stockholm 25
Santa Cruz 22
Buffalo 20
Chicago 16
New York 15
Khartoum 13
Alicante 10
Cedar Knolls 9
Milan 9
Fairfield 8
Rome 8
Seattle 8
Shanghai 8
Bremen 7
Fleming Island 7
Houston 7
Oviedo 7
Baghdad 6
Dallas 6
Mountain View 6
Mumbai 6
Riyadh 6
Southend 6
Woodbridge 6
Helsinki 5
Hermanus 5
Tokyo 5
Brooklyn 4
Caivano 4
London 4
Los Angeles 4
Sydney 4
Ann Arbor 3
Bangkok 3
Barcelona 3
Beijing 3
Boardman 3
Chengdu 3
Council Bluffs 3
Cranston 3
Guangzhou 3
Hanoi 3
Henderson 3
Las Vegas 3
Media 3
Paris 3
Pittsburgh 3
Ravenna 3
St Petersburg 3
Wilmington 3
Ankara 2
Antwerp 2
Atlanta 2
Aurora 2
Boise 2
Brussels 2
Buenos Aires 2
Cairo 2
Cambridge 2
Cape Town 2
Carpaneto Piacentino 2
Chennai 2
Dhaka 2
Dhanbad 2
Granada 2
Harbin 2
Hefei 2
Kowloon 2
La Paz 2
Lake Forest 2
Larissa 2
Linyi 2
Maltepe 2
Milpitas 2
Novi Beograd 2
San Francisco 2
Sapulpa 2
Shahedshahr 2
The Hague 2
Torrile 2
Washington 2
Yazd 2
Al Muharraq 1
Albuquerque 1
Algiers 1
Amsterdam 1
Andria 1
Athens 1
Austin 1
Baltimore 1
Bat Yam 1
Berlin 1
Beverlo 1
Birkirkara 1
Birmingham 1
Borås 1
Boscotrecase 1
Totale 553
Nome #
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?, file e1dcb337-69ef-7715-e053-1705fe0a6cc9 131
Experience with regorafenib in the treatment of hepatocellular carcinoma, file e1dcb339-0004-7715-e053-1705fe0a6cc9 98
Antinuclear antibodies in COVID 19, file e1dcb338-d0dd-7715-e053-1705fe0a6cc9 87
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis, file e1dcb332-72b3-7715-e053-1705fe0a6cc9 68
Assessing the impact of COVID-19 on liver cancer management (CERO-19), file e1dcb339-c4a7-7715-e053-1705fe0a6cc9 66
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, file e1dcb335-54a5-7715-e053-1705fe0a6cc9 60
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role, file e1dcb336-0cd3-7715-e053-1705fe0a6cc9 57
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders, file e1dcb338-bc0f-7715-e053-1705fe0a6cc9 31
Anti-ganglioside antibodies and celiac disease, file e1dcb338-96a0-7715-e053-1705fe0a6cc9 18
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment, file e1dcb338-ee50-7715-e053-1705fe0a6cc9 14
Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods, file f3394bc9-05f4-4a2c-92cf-ffae3db9a064 13
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease, file 09befa93-c64e-4b8a-bbfa-f341a687cb7a 12
Autoantibodies to speckled protein family in primary biliary cholangitis, file e1dcb338-b788-7715-e053-1705fe0a6cc9 12
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials, file e1dcb338-fa95-7715-e053-1705fe0a6cc9 12
Radiological Features of Microvascular Invasion of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease, file 3c5db8af-7735-46f3-930d-af029245cafe 11
Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5), file e1dcb338-a297-7715-e053-1705fe0a6cc9 11
Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?, file 16c0e064-749a-4bfd-ba51-ee195adf800f 10
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib, file e1dcb337-002f-7715-e053-1705fe0a6cc9 10
Yttrium90 radioembolization versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis, file e1dcb32e-9da4-7715-e053-1705fe0a6cc9 9
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation., file e1dcb330-f623-7715-e053-1705fe0a6cc9 9
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting, file e1dcb338-c41a-7715-e053-1705fe0a6cc9 9
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers, file f14c8394-3ca3-4be2-b4da-8aeb3ee61b47 9
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file 118f5927-936a-452d-bd26-5f632b16207e 8
The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma, file 2560353f-993a-4d3c-8d99-c4e48f27f962 8
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file 2b038eb6-ebe6-40e5-b251-f57824801171 8
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file bfd47a8d-e568-4bec-9a81-98e4f47daa7f 8
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, file e1dcb335-9601-7715-e053-1705fe0a6cc9 8
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file e1dcb339-0e34-7715-e053-1705fe0a6cc9 8
The evolutionary scenario of hepatocellular carcinoma in Italy: an update., file e1dcb32f-4175-7715-e053-1705fe0a6cc9 7
Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis, file e1dcb338-9870-7715-e053-1705fe0a6cc9 7
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma, file e1dcb338-c1db-7715-e053-1705fe0a6cc9 7
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis, file 20ee745a-661b-427a-8021-a555e275cf42 6
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database, file e1dcb32c-c709-7715-e053-1705fe0a6cc9 6
Trans-tace: Prognostic role of the transient hypertransaminasemia after conventional chemoembolization for hepatocellular carcinoma, file e1dcb338-aa97-7715-e053-1705fe0a6cc9 6
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file d27ea406-442d-41d5-9c57-319af1b819d3 5
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study., file e1dcb32e-8b8a-7715-e053-1705fe0a6cc9 5
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file e1dcb339-97cc-7715-e053-1705fe0a6cc9 5
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence, file 5ce5428b-f1d8-49e9-8361-a47d6627a3ba 4
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?, file 5b4fa588-7281-4b94-aad0-fe95452eccc2 3
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors, file 7bfea7b3-e2f0-4803-9681-35a0471e7a52 3
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease, file c6f16260-5b78-46cd-87c3-1eb239e6ae6f 3
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC, file f5a942b2-3275-42c5-9aa4-4273688464dd 3
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time, file 3a672b80-0d65-4e16-a0a9-6d0bc01d270c 2
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management, file d6c3b842-4e0a-4c5f-8179-3a41c52f3122 2
Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases., file e1dcb32d-22dd-7715-e053-1705fe0a6cc9 2
null, file e1dcb32f-575f-7715-e053-1705fe0a6cc9 2
Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia/osteoporosis, file e1dcb332-3d98-7715-e053-1705fe0a6cc9 2
The changing scenario of hepatocellular carcinoma in Italy: an update, file 018f1cec-a209-41c4-ab00-402e5158d9b0 1
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma, file 473dc475-b8ca-4079-a115-c4d2dc3af6d9 1
Assessing the impact of COVID-19 on liver cancer management (CERO-19), file b7b26322-e78b-4fee-8fa7-320d9aad285f 1
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma, file d9ec9a0a-da2a-469d-af0a-c6daa26776b1 1
null, file e1dcb32d-bb7f-7715-e053-1705fe0a6cc9 1
null, file e1dcb32f-0dc9-7715-e053-1705fe0a6cc9 1
null, file e1dcb32f-31ce-7715-e053-1705fe0a6cc9 1
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma, file e1dcb330-6782-7715-e053-1705fe0a6cc9 1
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives, file e1dcb331-f186-7715-e053-1705fe0a6cc9 1
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial, file e1dcb332-ebcc-7715-e053-1705fe0a6cc9 1
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver, file e1dcb336-333c-7715-e053-1705fe0a6cc9 1
Coronavirus disease associated immune thrombocytopenia: Causation or correlation?, file e1dcb336-ef1f-7715-e053-1705fe0a6cc9 1
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?, file e1dcb337-0038-7715-e053-1705fe0a6cc9 1
Totale 898
Categoria #
all - tutte 3.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 1 0 0 0 0 0 1 0 0 0
2020/202147 3 8 0 1 0 4 7 3 6 7 5 3
2021/2022113 4 5 3 13 9 6 6 7 7 5 29 19
2022/2023511 49 37 44 35 31 37 32 45 81 38 50 32
2023/2024212 34 38 37 50 49 4 0 0 0 0 0 0
Totale 898